Since 2005, the SSRI paroxetine, first marketed by GlaxoSmithKline as Seroxat, has carried warnings of risk of birth defects. In the US litigation in which I have been asked to give evidence, the plaintives will argue that, even before they were launched, there was good laboratory evidence that the SSRIs might cause problems, and, following their initial marketing, evidence emerged over a decade ago from clinical use that the drugs actually do cause problems.
Yet these drugs have been actively promoted, de facto primarily to women of child-bearing years. How could this happen? More...
Don't miss:
- Young suffer Tamiflu side-effects...
- Harvard Medical School and Big Pharma...
- China distributes fake drugs in Africa under "Made in India" labels!!!
- India's waterways massively polluted by Big Pharma...
- How Big Pharma gets into bed with doctors and nurses...
- The family doctor and his 90,000 child porn images...
No comments:
Post a Comment